Isabel Rozas

8.5k total citations · 3 hit papers
179 papers, 7.4k citations indexed

About

Isabel Rozas is a scholar working on Organic Chemistry, Molecular Biology and Physical and Theoretical Chemistry. According to data from OpenAlex, Isabel Rozas has authored 179 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Organic Chemistry, 63 papers in Molecular Biology and 56 papers in Physical and Theoretical Chemistry. Recurrent topics in Isabel Rozas's work include Crystallography and molecular interactions (49 papers), Advanced Chemical Physics Studies (31 papers) and Synthesis and Characterization of Heterocyclic Compounds (27 papers). Isabel Rozas is often cited by papers focused on Crystallography and molecular interactions (49 papers), Advanced Chemical Physics Studies (31 papers) and Synthesis and Characterization of Heterocyclic Compounds (27 papers). Isabel Rozas collaborates with scholars based in Ireland, Spain and United Kingdom. Isabel Rozas's co-authors include José Elguero, Ibón Alkorta, Christophe Dardonville, Enrique Espinosa, Elı́es Molins, Fernando Rodrı́guez, Brendan Kelly, Luís F. Callado, Cristina Trujillo and Pilar Goya and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and The Journal of Chemical Physics.

In The Last Decade

Isabel Rozas

176 papers receiving 7.3k citations

Hit Papers

Behavior of Ylides Containing N, O, and C Atoms as Hydrog... 1998 2026 2007 2016 2000 1998 2002 400 800 1.2k

Peers

Isabel Rozas
P. Gilli Italy
Yirong Mo United States
J. J. Dannenberg United States
James A. Platts United Kingdom
Ronald K. Castellano United States
B. Miehlich Germany
P. Gilli Italy
Isabel Rozas
Citations per year, relative to Isabel Rozas Isabel Rozas (= 1×) peers P. Gilli

Countries citing papers authored by Isabel Rozas

Since Specialization
Citations

This map shows the geographic impact of Isabel Rozas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Rozas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Rozas more than expected).

Fields of papers citing papers by Isabel Rozas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Rozas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Rozas. The network helps show where Isabel Rozas may publish in the future.

Co-authorship network of co-authors of Isabel Rozas

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Rozas. A scholar is included among the top collaborators of Isabel Rozas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Rozas. Isabel Rozas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Previtali, Viola, et al.. (2025). Platinum(ii) complexes of aryl guanidine-like derivatives as potential anticancer agents: between coordination and cyclometallation. RSC Advances. 15(5). 3427–3438. 1 indexed citations
2.
Rozas, Isabel, et al.. (2024). Searching for “Greener” Bioequivalents of CF3 to Lower its Environmental Impact. Chemistry - A European Journal. 30(50). e202401954–e202401954. 1 indexed citations
3.
Gandin, Valentina, et al.. (2023). Novel design of dual-action Pt(iv) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib. Dalton Transactions. 52(39). 14110–14122. 5 indexed citations
4.
Rozas, Isabel, et al.. (2023). Simultaneous Hydrogen Bonds with Different Binding Modes: The Acceptor “Rules” but the Donor “Chooses”. Chemistry - A European Journal. 29(21). e202300717–e202300717. 2 indexed citations
5.
Rozas, Isabel, et al.. (2023). Green synthesis of nitroaryl thioureas: Towards an improved preparation of guanidinium DNA binders. Bioorganic & Medicinal Chemistry Letters. 90. 129346–129346. 1 indexed citations
6.
Besada, Pedro, Isabel Rozas, José Brea, et al.. (2022). Novel Pyridazin-3(2H)-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity. ACS Medicinal Chemistry Letters. 13(3). 463–469. 7 indexed citations
7.
Prencipe, Filippo, Aishah M. Alsibaee, Aisling M. Towell, et al.. (2022). Allantodapsone is a Pan-Inhibitor of Staphylococcus aureus Adhesion to Fibrinogen, Loricrin, and Cytokeratin 10. Microbiology Spectrum. 10(3). e0117521–e0117521. 6 indexed citations
8.
Previtali, Viola, et al.. (2020). Exploring the Anti-Cancer Mechanism of Novel 3,4′-Substituted Diaryl Guanidinium Derivatives. Pharmaceuticals. 13(12). 485–485. 3 indexed citations
9.
Kelly, Brendan, Fernando Rodrı́guez, Aintzane García‐Bea, et al.. (2020). Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity. European Journal of Medicinal Chemistry. 209. 112947–112947. 4 indexed citations
10.
Ullah, Hussain, Viola Previtali, Brendan Twamley, et al.. (2019). Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines. European Journal of Medicinal Chemistry. 181. 111544–111544. 76 indexed citations
11.
García‐Bea, Aintzane, et al.. (2016). Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors’ binding pocket. European Journal of Medicinal Chemistry. 123. 48–57. 15 indexed citations
12.
Rozas, Isabel, et al.. (2014). Understanding the Guanidine‐Like Cationic Moiety for Optimal Binding into the DNA Minor Groove. ChemMedChem. 9(9). 2065–2073. 14 indexed citations
13.
Muguruza, Carolina, Fernando Rodrı́guez, Isabel Rozas, et al.. (2012). Antidepressant-like properties of three new α2-adrenoceptor antagonists. Neuropharmacology. 65. 13–19. 19 indexed citations
14.
Evans, Paul, et al.. (2012). Regioselectivity in the Intramolecular Heck Reaction of a Series of Cyclic Sulfonamides: An Experimental and Computational Study. Chemistry - A European Journal. 18(42). 13379–13387. 14 indexed citations
15.
Margison, Geoffrey P., et al.. (2011). Towards more specific O6-methylguanine-DNA methyltransferase (MGMT) inactivators. Bioorganic & Medicinal Chemistry. 19(5). 1658–1665. 5 indexed citations
16.
Quinn, Susan J., John M. Kelly, Daniel H. O’Donovan, et al.. (2010). Understanding the DNA binding of novel non-symmetrical guanidinium/2-aminoimidazolinium derivatives. Organic & Biomolecular Chemistry. 8(24). 5558–5558. 34 indexed citations
17.
Rozas, Isabel. (2007). On the nature of hydrogen bonds: an overview on computational studies and a word about patterns. Physical Chemistry Chemical Physics. 9(22). 2782–2782. 158 indexed citations
18.
Kinsella, Gemma K., Isabel Rozas, & Graeme W. Watson. (2005). Modelling the Interaction of Catecholamines with the α1A Adrenoceptor Towards a Ligand-induced Receptor Structure. Journal of Computer-Aided Molecular Design. 19(6). 357–367. 3 indexed citations
19.
Kinsella, Gemma K., Isabel Rozas, & Graeme W. Watson. (2004). Computational study of the α1A adrenoceptor. Biochemical and Biophysical Research Communications. 324. 1 indexed citations
20.
Dardonville, Christophe, Isabel Rozas, Pilar Goya, et al.. (2003). Synthesis and analgesic activity of a series of new azaalkane bis-guanidinium and bis(2-aminoimidazolinium) compounds. Bioorganic & Medicinal Chemistry. 11(7). 1283–1291. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026